⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 17, 2021Diabetes TherapyOpen Access

Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis

Sarah Zimner Rapuch Victoria Divino Kirsi Norrbacka Kristina S. Boye Jérémie Lebrec Myriam Rosilio Mitch DeKoven Bruno Guerci

View Full Paper

Ask AI

Bookmark

Share

Abstract

This analysis revealed marked differences in persistence among GLP-1 RAs, which was highest for dulaglutide and lowest for exenatide BID. The prospective TROPHIES study will provide additional information about persistence with dulaglutide and liraglutide, including reasons for treatment modifications.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rapuch et al. (2021) studied this question.

synapsesocial.com/papers/69dabff54e9a02dbaa68464c https://doi.org/10.1007/s13300-021-01055-5

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Original Research · 2018 · 3,516 citations
22019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Original Research · 2019 · 1,191 citations
39. Pharmacologic Approaches to Glycemic Treatment: <i>Standards of Medical Care in Diabetes—2020</i>Original Research · 2019 · 913 citations
4Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatmentRetrospective Study · 2017 · 51 citations
5Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: a 5‐year survival analysisRetrospective Study · 2018 · 14 citations

Lack of Treatment Persistence and Treatment Nonadherence as Barriers to Glycaemic Control in Patients with Type 2 Diabetes2019
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data2019
Glucagon-Like Peptide-1 Receptor Agonist Treatment Patterns Among Type 2 Diabetes Patients in Six European Countries2014
A Malaysian Expert Consensus on The Identification, Evaluation, and Pharmacological Management of Diabetic Sensorimotor PolyneuropathyDiabetes Therapy · 2026
Clinical Performance of the IWGDF Risk Stratification System for Diabetic Foot Ulceration: A Gender-Disaggregated Study of 713 PatientsDiabetes Therapy · 2026

More from Diabetes Therapy

More from Eli Lilly (United States)

More from Université de Lorraine

More from IQVIA (United States)